DOI 10.1186/s12967-025-07331-3
Regulation of m6A methylation in the immune microenvironment in the development of diabetes mellitus.
Аннотация
Diabetes mellitus is a widespread metabolic disorder characterized by chronic hyperglycemia, driven primarily by insulin resistance and β-cell dysfunction. N6-methyladenosine (m6A), the most prevalent internal RNA modification in eukaryotes, has emerged as a critical regulator in diabetes pathogenesis. This review outlines how m6A methylation, mediated by writers (METTL3, METTL14), erasers (FTO, ALKBH5), and readers (YTHDFs, IGF2BPs), influences key diabetic processes including β-cell function, lipid metabolism, and insulin resistance. A key focus is on the role of m6A in modulating the immune microenvironment, such as by regulating macrophage polarization and T-cell activity, which contributes to inflammation and disease progression in both type 1 and type 2 diabetes. Furthermore, m6A dysregulation is implicated in multiple diabetic complications. Therapeutic agents, including existing drugs, natural extracts, and specific m6A inhibitors, can modulate m6A levels, highlighting its potential as a therapeutic target. This review synthesizes the evidence linking m6A to diabetes, with an emphasis on immunoregulation, and suggests that targeting m6A pathways offers promise for future treatments.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.